002773 Chengdu Kanghong Pharmaceutical Group
- 19.99
- -0.50-2.44%
Chengdu Kanghong Pharmaceutical Group News
Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Announcement on reaching the exercise conditions for the second exercise period of the 2022 Stock Value-added Rights Incentive Plan
Kanghong Pharmaceutical: Notice on Cancellation of Some Stock Options under the 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on Cancellation of Part of the Stock Options Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021 Stock Option Incentive Plan
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the Achievement of the Enforcement Conditions for the Second Exercise Period of the 2022 Stock Value-added Rights Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan granting autonomous exercise rights for part of the third exercise period for the first time
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan to reserve the right to exercise independently during part of the second exercise period
Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan
Chengdu Kanghong Pharmaceutical Group: The list of eligible incentive recipients for the first grant of stock options under the 2021 stock option incentive plan includes the partially vested third exercise period and the reserved second exercise period.
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Tongshang (Shenzhen) Law Firm on the Cancellation of Certain Stock Options and the Achievement of Exercise Conditions for the Third Exercise Period of Certain Stock Options and the Reservation of Granting Certain Stock Options for the Second Exercise Period of Chengdu Kanghong Pharmaceutical Group Co., Ltd.'s 2021 Stock Option Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Announcement regarding the achievement of the exercise conditions for the first exercise period of the 2021 stock options incentive plan and the reservation of the second exercise period
Chengdu Kanghong Pharmaceutical Group: Announcement on the cancellation of a portion of stock options in the 2021 stock option incentive plan.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2022 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2023 Stock Value-added Rights Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2021 stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the company's 2021 stock option incentive plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of Chengdu Kanghong Pharmaceutical Group Co., Ltd. 2022 Stock Value-added Incentive Plan
Chengdu Kanghong Pharmaceutical Group: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the adjustment of the exercise price of the 2023 Stock Value-added Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group: Notice on the implementation of equity allocation for the year 2023
Kanghong Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
No Data
